Cambridge Healthtech Institute’s Fifth Annual

Point-of-Care Diagnostics

Examining Rapid Diagnostics from Clinic to Consumer

March 10-11, 2016 | Hilton San Francisco Union Square | San Francisco, CA
Part of the 23rd International Molecular Medicine Tri-Conference


Point-of-care testing is becoming a crucial component of healthcare both in an out of the clinical setting. Rapid care centers are now commonplace in many pharmacies and mobile diagnostics applications are allowing the consumer to take their health into their own hands. Cambridge Healthtech Institute's Fifth Annual Point-of-Care Diagnostics symposium will examine how point of care is being used in the clinic, in pharmacies, and by the consumer. Point-of-care test developers and end users will address barriers to implementation and present solutions to encourage adoption. Finally, innovative point-of-care and mobile health technologies will be presented to showcase the latest tools and provide insights into the future of the field.

Preliminary Agenda


Point-of-Care at the Doctor’s Office
The Inconvenient Truth about Near Patient Testing at Doctor’s Office

Elsie Yu, Ph.D., DABCC, FACB, System Director, Toxicology and Point-of-Care Testing; Associate Director, Clinical Chemistry, Geisinger Medical Laboratories

Save a Penny, Lose a Dollar: POC vs. Central Lab Testing in the Hospital Setting

Gyorgy Abel, M.D., Ph.D., Director, Clinical Chemistry and Molecular Diagnostics, Lahey Hospital & Medical Center

Point-of-Care in the Pharmacy; Shifting the Paradigm: Bringing Lab Services to the Corner Drugstore

Casey Kozlowski , RPh, MBA, Director, Diagnostic Testing Product Development, Walgreens

Implementing Collaborative, Community Pharmacy-Based Disease Management Programs Using CLIA-Waived POC Tests

Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy

Presentation to be Announced

Luncheon Presentation to be Announced

Direct-to-Consumer Point-of-Care
Consumer Telehealth in Retail Settings: Reception, Responses and the Road Ahead

Gail B. Croall, MD, FAAP, CMO, HealthSpot


Bringing Point-of-Care Testing to the “Internet of Things”

Pat Arensdorf, MBA, Principal, Halteres Associates, LLC
Katya Ledin, Ph.D., MPH, Director, Napa-Solano-Yolo-Marin County Public Health Laboratory
James Killeen, M.D., Clinical Director of Informatics Fellowship, Associate Director Information Services, Director Beach Program, University of California San Diego Department of Emergency Medicine

Profound Need to Substantiate Health Economic Claims for POC Testing

Katherine Tynan Ph.D., Tynan Consulting LLC


Polystyrene Plastics for Production of On-Demand Antibody Arrays for Point-of-Care Detection

Matthew A. Coleman, Ph.D., Physics and Life Sciences, BBTD, L-452, Lawrence Livermore National Laboratory

The Potential for Single Molecule Fluorescence Methods in Point-of-Care Technologies

Ted A. Laurence, Ph.D., Materials Science Division, Physics and Life Sciences, Lawrence Livermore National Laboratory

Next-Generation Point-of-Care Testing: Clinical Needs, Technologies and Opportunities

Ping Wang, Ph.D., Director, Clinical Chemistry, Pathology and Genomic Medicine, Houston Methodist Hospital

Presentation to be Announced


Giving the Patient Power - Opening Pandora's Box or Future Enlightenment?

Francis White, EU General Manager, AliveCor Ltd.

Biomarker-Based Diagnosis of Alzheimer’s Disease Using Acoustic Detection Techniques

Samantha Swarbrick, Ph.D., Student, Mechanical and Manufacturing Engineering, Loughborough University

Premier Sponsors:  

Bina Technologies



Jackson Laboratory - small logo 


 Precision for Medicine 


Silicon Biosystems

Thomson Reuters-Large